Neuro-Oncology
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
DDDR-03. DEVELOPMENT OF NOVEL ANTI-BRAIN METASTASIS INHIBITORS.
24:vii98-vii99.
2022
-
EPCO-07. NON-GENOMIC DETERMINANTS OF TUMOR CELL PHENOTYPES IN ADULT GLIOBLASTOMA.
24:vii117-vii117.
2022
-
EXTH-81. ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA.
24:vii228-vii228.
2022
-
MODL-05. DISCOVERY OF DYNAMIC MINIMAL RESIDUAL DISEASE STATES IN ADULT GLIOBLASTOMA USING SINGLE CELL TECHNOLOGY.
24:vii291-vii292.
2022
-
Low and steady wins the race: For melanoma brain metastases, is prevention better than a cure?.
24:226-228.
2022
-
EXTH-53. ANTI-ROBO1 CAR T CELLS EFFECTIVELY TARGET MALIGNANT BRAIN CANCER.
23:vi175-vi175.
2021
-
STEM-02. THERAPEUTIC INTERVENTION OF LUNG-, BREAST-, AND MELANOMA-BRAIN METASTASIS.
23:vi21-vi21.
2021
-
STEM-05. FUNCTIONAL MAPPING REVEALS WIDESPREAD REMODELLING AND UNRECOGNIZED PATHWAY DEPENDENCIES IN RECURRENT GLIOBLASTOMA.
23:vi22-vi22.
2021
-
TMOD-01. AN IN VIVO FUNCTIONAL GENOMICS SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS.
23:vi215-vi215.
2021
-
TMOD-15. CHARACTERIZATION OF THE MINIMAL RESIDUAL DISEASE STATE REVEALS DISTINCT EVOLUTIONARY TRAJECTORIES OF HUMAN GLIOBLASTOMA.
23:vi218-vi218.
2021
-
EPCT-11. RURALITY INDEX SCORE AND PEDIATRIC NEURO-ONCOLOGICAL OUTCOME IN ONTARIO.
23:i49-i49.
2021
-
EPCT-11. RURALITY INDEX SCORE AND PEDIATRIC NEURO-ONCOLOGICAL OUTCOME IN ONTARIO.
23:i49-i49.
2021
-
EPCT-12. NATIONAL MULTICENTERED RETROSPECTIVE REVIEW OF DEMOGRAPHIC, TUMOUR AND INTRAOPERATIVE FEATURES ASSOCIATED WITH THE DEVELOPMENT OF CEREBELLAR MUTISM AFTER PEDIATRIC POSTERIOR FOSSA TUMOUR RESECTION.
23:i49-i49.
2021
-
MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA.
22:iii399-iii399.
2020
-
MBRS-01. DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA.
22:iii399-iii399.
2020
-
STEM-01. TARGETING BRAIN METASTASIS-INITIATING CELLS: A PREVENTATIVE APPROACH.
22:ii196-ii196.
2020
-
TAMI-03. IDENTIFICATION OF NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS THROUGH IN VIVO FUNCTIONAL GENOMICS.
22:ii213-ii213.
2020
-
STEM-27. LEVERAGING FUNCTIONAL GENETIC DEPENDENCIES IN TREATMENT-REFRACTORY GLIOBLASTOMA.
21:vi239-vi239.
2019
-
MEDU-25. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICs CONTRIBUTE TO THERAPY EVASION AND RELAPSE.
21:ii108-ii108.
2019
-
MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA.
21:ii112-ii113.
2019
-
THER-14. SMALL MOLECULE INHIBITOR TARGETING SELF-RENEWAL AS A THERAPEUTIC OPTION FOR RECURRENT MEDULLOBLASTOMA.
21:ii117-ii117.
2019
-
MEDU-44. MUSASHI-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA.
21:ii112-ii113.
2019
-
GENE-21. A COMMON FETAL DEVELOPMENTAL ORIGIN FOR PFA EPENDYMOMA, PFB EPENDYMOMA, AND CEREBELLAR PILOCYTIC ASTROCYTOMAS?.
20:vi107-vi107.
2018
-
PDTM-21. MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA.
20:vi208-vi208.
2018
-
RBTT-04. DOES EXERCISE IMPROVE PROGRESSION FREE SURVIVAL AND QUALITY OF LIFE IN PATIENTS WITH GLIOBLASTOMA? A TRIAL IN PROGRESS.
20:vi234-vi235.
2018
-
TMOD-23. DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY.
20:vi273-vi273.
2018
-
MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE.
20:i119-i119.
2018
-
MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA.
20:i133-i133.
2018
-
MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE.
20:i119-i119.
2018
-
MBRS-24. INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA.
20:i133-i133.
2018
-
CMET-35. PRELIMINARY SCREENING OF A NOVEL EpCAM BISPECIFIC T-CELL ENGAGER (BiTE) ANTIBODY TO TARGET A BMIC POPULATION IN HUMAN BRAIN METASTASES.
19:vi46-vi46.
2017
-
CMET-47. PRECLINICAL VALIDATION OF NOVEL THERAPEUTICS TARGETING A BMIC POPULATION IN HUMAN BRAIN METASTASES.
19:vi49-vi49.
2017
-
CSIG-22. A CD133-Akt-Wnt SIGNALING AXIS PROVIDES FUNCTIONAL INSIGHT INTO THE ROLE OF CD133 IN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS.
19:vi54-vi54.
2017
-
EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA.
19:vi72-vi72.
2017
-
IMMU-03. THERAPEUTIC TARGETING OF TUMORIGENIC
EphA2+/EphA3+ BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA.
19:vi113-vi113.
2017
-
STEM-17. CHARACTERIZATION OF THE CELL SURFACE PROTEOME IN RECURRENT GLIOBLASTOMA INITIATING CELLS.
19:vi229-vi229.
2017
-
STEM-21. CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL Wnt PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS.
19:vi230-vi230.
2017
-
STEM-42. GENOME-WIDE CRISPR SCREENS IN BRAIN TUMOR INITIATING CELLS (BTICS) IDENTIFY POTENT SENSITIZERS OF CONVENTIONAL CHEMORADIOTHERAPY.
19:vi234-vi235.
2017
-
TMOD-02. IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA.
19:vi254-vi254.
2017
-
TMOD-03. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE.
19:vi255-vi255.
2017
-
TMOD-06. CLONAL DYNAMICS OF HUMAN GLIOBLASTOMA IN RESPONSE TO CHEMORADIOTHERAPY.
19:vi255-vi255.
2017
-
EPID-17. A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA.
19:vi72-vi72.
2017
-
MEDU-30. GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE.
19:iv44-iv44.
2017
-
TRTH-13. BMI1 IS A THERAPEUTIC TARGET IN RECURRENT MEDULLOBLASTOMA.
19:iv54-iv54.
2017
-
TRTH-29. CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL WNT PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS.
19:iv58-iv58.
2017
-
OS07.2 Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the ARTE trial.
19:iii13-iii13.
2017
-
Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training.
19:now177-now177.
2017
-
IMST-53. THE EFFICACY OF CD133 BiTEs AND CAR-T CELLS IN PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA.
18:vi98-vi98.
2016
-
TMOD-02. Developing models of therapy resistance for the identification of treatment-refractory cell population(s) in human glioblastoma.
18:vi207-vi207.
2016
-
TMOD-23. DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO- BRAIN METASTASIS TO IDENTIFY GENETIC REGULATORS OF BRAIN METASTASIS INITIATING CELLS.
18:vi211-vi212.
2016
-
TMOD-37. CHARACTERIZATION OF A UNIQUE BMIC POPULATION IN HUMAN BRAIN METASTASES.
18:vi214-vi215.
2016
-
AT-03ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?.
18:iii1.2-iii1.
2016
-
CMS-02MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM.
18:iii16.2-iii16.
2016
-
EPI-04DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?.
18:iii40.3-iii40.
2016
-
MB-22ACTIVATED Wnt SIGNALING FOR THE THERAPEUTIC TARGETING OF TREATMENT-REFRACTORY MEDULLOBLASTOMA STEM CELLS.
18:iii101.3-iii101.
2016
-
QOS-06REPAIRING THE BRAIN WITH PHYSICAL EXERCISE: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS. INSIGHTS FROM CORTICAL THICKNESS ANALYSIS AND DEFORMATION BASED MORPHOMETRY.
18:iii146.2-iii146.
2016
-
QOS-21A MODEL OF CARE FOR PEDIATRIC CNS TUMOR PATIENTS.
18:iii149.4-iii149.
2016
-
QOS-41NEURAL NETWORK DISTURBANCES IN CHILDREN TREATED FOR BRAIN TUMOURS.
18:iii154.2-iii154.
2016
-
CMS-02MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM.
18:iii16-iii16.
2016
-
Comparative genomic and genetic analysis of glioblastoma-derived brain tumor-initiating cells and their parent tumors.
18:350-360.
2016
-
ATPS-92Bmi1 IDENTIFIES TREATMENT-REFRACTORY STEM CELLS IN HUMAN GLIOBLASTOMA.
17:v38.4-v39.
2015
-
BMET-31DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO-BRAIN METASTASIS TO IDENTIFY UNIQUE METASTATIC GENE SIGNATURES.
17:v51.5-v52.
2015
-
STEM-23PYRVINIUM TARGETS CD133 IN HUMAN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS.
17:v213.1-v213.
2015
-
Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis.
17:868-881.
2015
-
Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.
17:822-831.
2015
-
MB-14 * DISCOVERING THE TREATMENT REFRACTORY BTIC POPULATION IN GROUP 3 MEDULLOBLASTOMA.
17:iii22-iii22.
2015
-
MB-15 * ACTIVATED Wnt SIGNALING TARGETS Sox2+ TREATMENT-REFRACTORY Shh-DEPENDENT MEDULLOBLASTOMA STEM CELLS.
17:iii23-iii23.
2015
-
Optic pathway gliomas in adolescence--time to challenge treatment choices?.
15:391-400.
2013
-
Diffusion tensor imaging of white matter after cranial radiation in children for medulloblastoma: Correlation with IQ.
8:244-252.
2006
-
Low-risk meningioma: Initial outcomes from NRG Oncology/RTOG 0539.
2023
-
DEVELOPMENT OF NOVEL ANTI-BRAIN METASTASIS INHIBITORS
2022
-
DISCOVERY OF DYNAMIC MINIMAL RESIDUAL DISEASE STATES IN ADULT GLIOBLASTOMA USING SINGLE CELL TECHNOLOGY
2022
-
ITGA5 IS A NOVEL IMMUNOTHERAPEUTIC TARGET AGAINST TREATMENT REFRACTORY MEDULLOBLASTOMA
2022
-
NON-GENOMIC DETERMINANTS OF TUMOR CELL PHENOTYPES IN ADULT GLIOBLASTOMA.
2022
-
AN IN VIVO FUNCTIONAL GENOMICS SCREEN TO IDENTIFY NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS
2021
-
ANTI-ROBO1 CAR T CELLS EFFECTIVELY TARGET MALIGNANT BRAIN CANCER
2021
-
FUNCTIONAL MAPPING REVEALS WIDESPREAD REMODELLING AND UNRECOGNIZED PATHWAY DEPENDENCIES IN RECURRENT GLIOBLASTOMA
2021
-
THERAPEUTIC INTERVENTION OF LUNG-, BREAST-, AND MELANOMA-BRAIN METASTASIS
2021
-
EMBR-22. RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA
2021
-
EPCT-12. NATIONAL MULTICENTERED RETROSPECTIVE REVIEW OF DEMOGRAPHIC, TUMOUR AND INTRAOPERATIVE FEATURES ASSOCIATED WITH THE DEVELOPMENT OF CEREBELLAR MUTISM AFTER PEDIATRIC POSTERIOR FOSSA TUMOUR RESECTION
2021
-
QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS
2020
-
QOL-46. LATE EFFECTS CARE FOR CHILDHOOD BRAIN TUMOUR SURVIVORS: A QUALITY IMPROVEMENT PROJECT
2020
-
DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
2020
-
PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS
2020
-
IDEAL TREATMENT REGIMEN FOR PATIENTS WITH >= 1 BRAIN METASTASIS FROM PRIMARY NON-SMALL-CELL LUNG CANCER - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
2020
-
IDENTIFICATION OF NOVEL DRIVERS OF LUNG-TO-BRAIN METASTASIS THROUGH IN VIVO FUNCTIONAL GENOMICS
2020
-
TARGETING BRAIN METASTASIS-INITIATING CELLS: A PREVENTATIVE APPROACH
2020
-
LEVERAGING FUNCTIONAL GENETIC DEPENDENCIES IN TREATMENT-REFRACTORY GLIOBLASTOMA
2019
-
MEDU-10. THERAPEUTIC TARGETING OF STEM CELL SELF-RENEWAL IN CHILDHOOD MEDULLOBLASTOMA: STRATEGIES FOR BLOCKING RECURRENCE
2019
-
GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE
2019
-
MUSAShi-1 IS A MASTER REGULATOR OF ABERRANT TRANSLATION IN GROUP 3 MEDULLOBLASTOMA
2019
-
SMALL MOLECULE INHIBITOR TARGETING SELF-RENEWAL AS A THERAPEUTIC OPTION FOR RECURRENT MEDULLOBLASTOMA
2019
-
A COMMON FETAL DEVELOPMENTAL ORIGIN FOR PFA EPENDYMOMA, PFB EPENDYMOMA, AND CEREBELLAR PILOCYTIC ASTROCYTOMAS?
2018
-
DOES EXERCISE IMPROVE PROGRESSION FREE SURVIVAL AND QUALITY OF LIFE IN PATIENTS WITH GLIOBLASTOMA? A TRIAL IN PROGRESS
2018
-
DYNAMIC PATTERNS OF GLIOBLASTOMA CLONAL EVOLUTION IN RESPONSE TO CHEMORADIOTHERAPY
2018
-
MATCHING OF SINGLE CELL TRANSCRIPTOMICS FROM CEREBELLAR DEVELOPMENT IDENTIFIES PUTATIVE SUBGROUP SPECIFIC CELLS OF ORIGIN FOR MEDULLOBLASTOMA
2018
-
USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN GLIOMA PATIENTS
2018
-
INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI 1 IN PEDIATRIC GROUP 3 MEDULLOBLASTOMA
2018
-
SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE
2018
-
A CD133-Akt-Wnt SIGNALING AXIS PROVIDES FUNCTIONAL INSIGHT INTO THE ROLE OF CD133 IN GLIOBLASTOMA BRAIN TUMOR-INITIATING CELLS
2017
-
A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA
2017
-
CHARACTERIZATION OF THE CELL SURFACE PROTEOME IN RECURRENT GLIOBLASTOMA INITIATING CELLS
2017
-
CLONAL DYNAMICS OF HUMAN GLIOBLASTOMA IN RESPONSE TO CHEMORADIOTHERAPY
2017
-
CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL WNT PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS
2017
-
GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE
2017
-
GENOME-WIDE CRISPR SCREENS IN BRAIN TUMOR INITIATING CELLS (BTICS) IDENTIFY POTENT SENSITIZERS OF CONVENTIONAL CHEMORADIOTHERAPY
2017
-
IDENTIFICATION OF NOVEL MARKERS OF TREATMENT-REFRACTORY RECURRENT GLIOBLASTOMA
2017
-
N107C/CEC.3 (ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY/CANADIAN CANCER TRIALS GROUP): PHASE III TRIAL OF POST-OPERATIVE RADIOSURGERY COMPARED WITH WHOLE BRAIN RADIOTHERAPY FOR RESECTED METASTATIC BRAIN DISEASE: COGNITIVE FUNCTION OF LONG-TERM SURVIVORS
2017
-
PRECLINICAL VALIDATION OF NOVEL THERAPEUTICS TARGETING A BMIC POPULATION IN HUMAN BRAIN METASTASES
2017
-
PRELIMINARY SCREENING OF A NOVEL EpCAM BISPECIFIC T-CELL ENGAGER (BiTE) ANTIBODY TO TARGET A BMIC POPULATION IN HUMAN BRAIN METASTASES
2017
-
PRETREATMENT VOLUME OF MRI-DETERMINED WHITE MATTER INJURY (WMI) PREDICTS COGNITIVE DECLINE AFTER HIPPOCAMPAL AVOIDANT (HA) WBRT FOR BRAIN METASTASES: SECONDARY ANALYSIS OF NRG ONCOLOGY RTOG 0933
2017
-
THERAPEUTIC TARGETING OF TUMORIGENIC EphA2+/EphA3+BRAIN TUMOR INITIATING CELLS WITH BISPECIFIC ANTIBODY IN HUMAN GLIOBLASTOMA
2017
-
CONTEXT-SPECIFIC TUMOR SUPPRESSIVE FUNCTION OF THE CANONICAL WNT PATHWAY IN PEDIATRIC MEDULLOBLASTOMA HIGHLIGHTS A THERAPEUTIC STRATEGY FOR TREATMENT-REFRACTORY SUBGROUPS
2017
-
GENES PRESERVING STEM CELL STATE IN GROUP 3 MB BTICS CONTRIBUTE TO THERAPY EVASION AND RELAPSE
2017
-
INVESTIGATING THE ROLE OF THE RNA BINDING PROTEIN, MUSASHI, IN GROUP 3 MEDULLOBLASTOMA
2017
-
CHARACTERIZATION OF A UNIQUE BMIC POPULATION IN HUMAN BRAIN METASTASES
2016
-
CHARACTERIZATION OF A UNIQUE BMIC POPULATION IN HUMAN BRAIN METASTASES
2016
-
DEVELOPMENT AND APPLICATION OF A NOVEL MODEL OF HUMAN LUNG-TO-BRAIN METASTASIS TO IDENTIFY GENETIC REGULATORS OF BRAIN METASTASIS INITIATING CELLS
2016
-
Developing models of therapy resistance for the identification of treatment-refractory cell population(s) in human glioblastoma
2016
-
THE EFFICACY OF CD133 BiTEs AND CAR-T CELLS IN PRECLINICAL MODEL OF RECURRENT GLIOBLASTOMA
2016
-
A MODEL OF CARE FOR PEDIATRIC CNS TUMOR PATIENTS
2016
-
ACTIVATED Wnt SIGNALING FOR THE THERAPEUTIC TARGETING OF TREATMENT-REFRACTORY MEDULLOBLASTOMA STEM CELLS
2016
-
ATYPICAL TERATOID RHABDOID TUMORS IN THE FIRST YEAR OF LIFE: SHOULD WE TREAT?
2016
-
DOES DIAGNOSTIC DELAY AFFECT MORBIDITY IN CHILDREN DIAGNOSED WITH BRAIN TUMOURS?
2016
-
IS A SEPARATE AFTERCARE CLINIC FOR PEDIATRIC CNS TUMOR PATIENTS NECESSARY?
2016
-
MRI AND SURGICAL PARAMETERS TO DETERMINE THE RISK OF A CEREBELLAR MUTISM
2016
-
NEURAL NETWORK DISTURBANCES IN CHILDREN TREATED FOR BRAIN TUMOURS
2016
-
PAEDIATRIC SPINAL EPENDYMOMA IN CANADA: A MULTICENTRE RETROSPECTIVE STUDY
2016
-
RELAPSE PATTERNS IN PEDIATRIC INTRACRANIAL EPENDYMOMA: A CANADIAN EXPERIENCE
2016
-
REPAIRING THE BRAIN WITH PHYSICAL EXERCISE: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS. INSIGHTS FROM CORTICAL THICKNESS ANALYSIS AND DEFORMATION BASED MORPHOMETRY
2016
-
ACTIVATED Wnt SIGNALING TARGETS Sox2+TREATMENT-REFRACTORY Shh-DEPENDENT MEDULLOBLASTOMA STEM CELLS
2015
-
DISCOVERING THE TREATMENT REFRACTORY BTIC POPULATION IN GROUP 3 MEDULLOBLASTOMA
2015
-
RADIATION THERAPY IS ASSOCIATED WITH INCREASED LATE MORTALITY IN LONG-TERM ADULT SURVIVORS OF CHILDHOOD LOW GRADE GLIOMA: A POPULATION BASED STUDY
2015
-
NC-10 * TRAINING THE BRAIN TO REPAIR ITSELF: AN EXERCISE TRIAL IN PEDIATRIC BRAIN TUMOR SURVIVORS
2014
-
RM-06 * IN VITRO CLONAL EVOLUTION OF GLIOBLASTOMA (GBM) BRAIN TUMOUR INITIATING CELLS (BTIC) TO MODEL TUMOUR RECURRENCE
2014
-
SC-33 * POLYCOMB GROUP PROTEIN Bmi1 CONTROLS NEURAL STEM AND PROGENITOR CELL MAINTENANCE AND GLIOBLASTOMA TUMOUR DEVELOPMENT
2014
-
IN VITRO ANALYSIS OF CYTOTOXIC EFFECTS OF BRIVARACETAM AND LACOSAMIDE ON HUMAN GLIOBLASTOMA CELLS
2014
-
GLIOMA SPECIFIC PEPTIDES: A PLATFORM FOR MOLECULAR IMAGING AND THERAPEUTIC TARGETING
2014
-
SOX2 IDENTIFIES THE TREATMENT-REFRACTORY STEM CELL POPULATION IN GROUP 2 MEDULLOBLASTOMA
2014
-
CLINICAL AND MOLECULAR DETERMINANTS OF LONG-TERM SURVIVAL IN CHILDREN WITH LOW GRADE GLIOMA; A POPULATION BASED STUDY
2014
-
EPIDEMIOLOGY OF MALIGNANT PONTINE GLIOMAS (MPG) IN THE PAEDIATRIC POPULATION IN CANADA: A STUDY OF THE CANADIAN PAEDIATRIC BRAIN TUMOUR CONSORTIUM (CPBTC)
2014
-
EXERCISE INCREASES HIPPOCAMPAL VOLUME IN CHILDREN TREATED WITH CRANIAL RADIATION
2014
-
NEUROCOGNITIVE EVALUATION OF LONG TERM SURVIVOR'S WITH ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): THE CANADIAN REGISTRY EXPERIENCE
2014
-
PERSONALIZING THE TREATMENT OF PEDIATRIC MEDULLOBLASTOMA: POLO-LIKE KINASE 1 AS A MOLECULAR TARGET IN HIGH-RISK CHILDREN
2014
-
PROGNOSTIC ADVANTAGE OF SURVEILLANCE NEUROIMAGING IN MANAGEMENT OF PEDIATRIC BRAIN TUMOURS
2014
-
DISTINGUISHING RESPONDERS FROM NON-RESPONDERS TO BEVACIZUMAB USING CT PERFUSION
2013
-
MEMORY PRESERVATION WITH CONFORMAL AVOIDANCE OF THE HIPPOCAMPUS DURING WHOLE- BRAIN RADIOTHERAPY (WBRT) FOR PATIENTS WITH BRAIN METASTASES: PRELIMINARY RESULTS OF RTOG 0933
2013
-
VERY LONG-TERM SURVIVAL OF PAEDIATRIC LOW GRADE GLIOMA PATIENTS; POSSIBLE ROLE OF BRAF-KIAA1549 FUSION
2013
-
WEEKLY VINBLASTINE IN CHEMOTHERAPY NAIVE CHILDREN AND ADOLESCENT WITH UNRESECTABLE OR PROGRESSIVE LOW GRADE GLIOMA: A CANADIAN COOPERATIVE STUDY
2013
-
Bmi1 REGULATES GLI ACETYLATION THROUGH CULLIN3 IN MEDULLOBLASTOMA STEM CELLS
2013
-
CLONAL EVOLUTION OF MEDULLOBLASTOMA BRAIN TUMOUR-INITIATING CELLS (BTICS) IN RESPONSE TO THERAPY: DISCOVERING THE REFRACTORY BTIC POPULATION
2013
-
MYXOPAPILLARY SPINAL EPENDYMOMAS DISPLAY A HIF1-ALPHA DRIVEN 'WARBURG' PHENOTYPE
2013
-
PERSONALIZING THE TREATMENT FOR MEDULLOBLASTOMA: POLO-LIKE KINASE 1 (PLK1) AS A MOLECULAR TARGET FOR THE SONIC HEDGEHOG (SHH) SUBTYPE
2013
-
REGULATION OF MEDULLOBLASTOMA STEM CELL SELF-RENEWAL THROUGH THE DEVELOPMENTALLY CONSERVED FoxG1-Bmi1-p21 AXIS
2013
-
CHARACTERIZATION OF GLIOMA USING ULTRA-HIGH-FIELD MR SPECTROSCOPIC IMAGING
2012
-
PRIMARY MALIGNANT BRAIN TUMORS IN THE ELDERLY: RETROSPECTIVE ANALYSIS OF MANAGEMENT AND OUTCOME
2012
-
Bmi1 AND FoxG1 REGULATE SELF-RENEWAL IN CD15+non-Shh/Wnt SUBTYPE MEDULLOBLASTOMA STEM CELLS THROUGH RECIPROCAL PROMOTER OCCUPANCY
2012
-
Bmi1 REGULATION OF SONIC HEDGEHOG SIGNALING THROUGH THE E3 UBIQUITIN LIGASE CULLIN3 IN MEDULLOBLASTOMA STEM CELLS
2012
-
CHILDREN SURVIVING BRAIN TUMORS HAVE HIGH RATES OF OBESITY INDEPENDENT OF PUBERTY
2012
-
DEVELOPMENT OF IN VITRO AND IN VIVO CHEMO-AND RADIOTHERAPY MODELS FOR DETECTION OF TREATMENT-REFRACTORY MEDULLOBLASTOMA BRAIN TUMOR-INITIATING CELLS
2012
-
FITNESS, PHYSICAL ACTIVITY AND BODY COMPOSITION FOLLOWING TREATMENT FOR A CNS TUMOUR
2012
-
FRACTIONATED STEREOTACTIC RADIOSURGERY FOR RELAPSED PAEDIATRIC PRIMITIVE NEUROECTODERMAL TUMOURS: A SINGLE INSTITUTION EXPERIENCE
2012
-
HIGH-GRADE PAPILLARY TUMOUR OF THE PINEAL REGION IN A YOUNG CHILD WITH LEPTOMENINGEAL DISEASE
2012
-
INCIDENCE OF MEDULLOBLASTOMA IN CANADIAN CHILDREN
2012
-
PARENTAL KNOWLEDGE AND HEALTH CARE SATISFACTION WITH NEUROFIBROMATOSIS TYPE 1
2012
-
PEDIATRIC AND ADULT MEDULLOBLASTOMA: WHAT MAKES THE DIFFERENCE IN OUTCOME?
2012
-
PEDIATRIC INTRACRANIAL GERMINOMA CASE SERIES: FOUR PATIENTS WITH ATYPICAL CLINICO-RADIOLOGICAL PRESENTATION
2012
-
POLO-LIKE KINASE 1 (PLK1) INHIBITION KILLS GLIOBLASTOMA MULTIFORME BRAIN TUMOUR CELLS IN PART THROUGH LOSS OF SOX2 AND DELAYS TUMOUR PROGRESSION IN MICE
2012
-
RECURRENT ANAPLASTIC EPENDYMOMA WITH EXTRACRANIAL METASTASES - TREATMENT WITH SURGERY, RADIATION AND ORAL CHEMOTHERAPY
2012
-
STRATIFICATION ACCORDING TO HGG-IMMUNO RPA MODEL PREDICTS OUTCOME IN PATIENTS WITH RELAPSED MALIGNANT GLIOMA TREATED BY ADJUVANT POSTOPERATIVE DC VACCINATION
2012
-
YB-1 BRIDGES NEURAL STEM CELLS AND BRAIN TUMOR-INITIATING CELLS VIA ITS ROLES IN DIFFERENTIATION AND CELL GROWTH
2012
-
BRAF-KIAA1549 FUSION PREDICTS BETTER CLINICAL OUTCOME IN PEDIATRIC LOW-GRADE ASTROCYTOMA
2011
-
GENOME-WIDE METHYLATED DNA RECOVERY IDENTIFIES FREQUENT HYPERMETHYLATION OF NOVEL TUMOR SUPPRESSOR GENES IN THE EPENDYMOMA EPIMETHYLGENOME
2011
-
ROLE OF YB-1 ON GLIAL TUMORS AND ITS PROMISE AS A MOLECULAR TARGET
2011
-
TARGETING POLO-LIKE KINASE FOR THE TREATMENT OF BRAIN TUMORS AND ITS UNIQUE CAPACITY TO ELIMINATE CANCER STEM CELLS THROUGH Sox-2 INHIBITION
2011
-
Y-BOX BINDING PROTEIN-1 (YB-1) INHIBITION TRIGGERS DIFFERENTIATION OF NORMAL AND CANCER STEM CELLS FROM THE BRAIN
2011
-
PROLONGED REMISSION OF GLIOBLASTOMA MULTIFORME WITH BEVACIZUMAB AND IRINOTECAN TREATMENT
2010
-
EPENDYMOMAS OF THE FILUM TERMINALE: A SINGLE-INSTITUTION EXPERIENCE
2010
-
A HUGE INTRACRANIAL CHORIOCARCINOMA IN A 10-YEAR-OLD BOY SUCCESSFULLY TREATED WITH MULTIDISCIPLINARY THERAPY INCLUDING ENDOVASCULAR EMBOLIZATION
2010
-
CEREBELLAR HEMANGIOBLASTOMA ASSOCIATED WITH VISCERAL AND CUTANEOUS HEMANGIOMATOSIS IN AN INFANT
2010
-
CLAUDIN-6 AND INI-1 IMMUNOHISTOCHEMICAL EXPRESSION IN ATYPICAL TERATOID RHABDOID TUMOURS OF THE CNS
2010
-
CNS ATYPICAL RHABDOID TUMOUR: THE CANADIAN PEDIATRIC BRAIN TUMOR CONSORTIUM EXPERIENCE
2010
-
IMMUNOTHERAPY INTEGRATED IN RADIOCHEMOTHERAPY AND MAINTENANCE TENIOZOLOMIDE: FINAL RESULTS OF THE HGG-2006 STUDY
2010
-
LATE EPENDYMOMA RELAPSES: A CANADIAN PEDIATRIC MULTICENTRE STUDY
2010
-
MANAGEMENT OF AN INTRACRANIAL MATURE TERATOMA RECURRING AS A GERMINOMA
2010
-
MEDULLOBLASTOMA OVER THREE DECADES IN A SINGLE INSTITUTION - WHAT HAVE WE ACHIEVED
2010
-
MORBIDITY IN LONG TERM SURVIVORS (> 10 YEARS) OF PEDIATRIC LOW GRADE GLIOMA
2010
-
MORTALITY IN PEDIATRIC LOW GRADE GLIOMA - A 25 YEARS POPULATION BASED STUDY
2010
-
PEDIATRIC NEUROONCOLOGY IN CANADA - DO WE HAVE A STANDARD OF CARE?
2010
-
REDEFINING THE INCIDENCE, OUTCOMES, AND PROGNOSTIC FACTORS FOR CNS ATYPICAL TERATOID RHABDOID TUMOURS AT BC CHILDREN'S HOSPITAL
2010
-
REGULATION OF BMI1 BY THE SHH PATHWAY IN HUMAN MEDULLOBLASTOMA BRAIN TUMOUR INITIATING CELLS
2010
-
THE CANADIAN PAEDIATRIC BRAIN TUMOUR CONSORTIUM (CPBTC): A NATIONAL NETWORK USING TELECONFERENCING
2010
-
DETECTING RECURRENCE IN MALIGNANT GLIOMA PATIENTS ON BEVACIZUMAB: MRI, SPECT CT, OR PET-WHICH IS BETTER?
2009
-
INTEGRATION OF DC VACCINATION IN THE PRIMARY TREATMENT OF ADULTS WITH GLIOBLASTOMA: FINAL RESULTS OF THE HGG-2006 PHASE I/II TRIAL
2009
-
PHASE II TRIAL OF CONVENTIONAL RADIOTHERAPY WITH STEREOTACTIC RADIOSURGERY TO HIGH-RISK TUMOR REGIONS AS DETERMINED BY MR SPECTROSCOPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
2009
-
PILOMYXOID ASTROCYTOMA IN TWO DIFFERENT AGE GROUPS
2009
-
RETROSPECTIVE STUDY TO IDENTIFY IF 99M TECHNETIUM-MIBI SPECT HAS THE SAME CORRELATION AS F-18-FLUORO-DEOXY-D-GLUCOSE PET WITH THE FINAL HISTOLOGICAL DIAGNOSIS ACCORDING TO WORLD HEALTH ORGANIZATION (WHO) CRITERIA IN PATIENTS WITH BRAIN TUMORS
2009
-
VALIDATION OF RPA CLASSIFICATION AS A PROGNOSTIC TOOL IN ADULT PATIENTS WITH RELAPSED HIGH-GRADE GLIOMA VACCINATED AT TIME OF RECURRENCE
2009
-
A RETROSPECTIVE REVIEW OF THE INCIDENCE OF BRAIN METASTASES IN PATIENTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER
2008
-
INTEGRATION OF DC VACCINATION IN THE PRIMARY TREATMENT OF ADULTS WITH GBM: UPDATE OF THE HGG-2006 PHASE I/II TRIAL
2008
-
OUTCOME OF PATIENTS WITH GLIOBLASTOMA MULTIFORME ARISING FROM SUBVENTRICULAR ZONE WHO WERE TREATED WITH CONCOMITANT RADIATION AND TEMOZOLOMIDE
2008
-
REFRACTORY CEREBROSPINAL FLUID LEAK WITH FATAL OUTCOME IN TWO PATIENTS WITH RECURRENT MALIGNANT GLIOMAS WHO WERE TREATED WITH BEVACIZUMAB AND IRINOTECAN AFTER GLIADEL WAFER PLACEMENT
2008
-
A population-based epidemiological study of childhood low-grade glioma
2008
-
Characterisation of the 4q12 amplicon in pediatric gliomas
2008
-
Feasibility and efficacy of second-line chemotherapy at recurrence for pediatric low-grade gliomas: A comparative population-based study
2008
-
High morbidity but low mortality in childhood spinal cord gliomas
2008
-
Inducible Cre recombinase activity in mouse mature astrocytes and adult neural precursor cells: Developing novel animal models for glioma
2008
-
More than words: Communication when a dying child can no longer speak
2008
-
Phase 1 and pharmacokinetic studies of erlotinib administered concurrently with and after radiotherapy for children, adolescents, and young adults with high-grade glioma
2008
-
Identification of known and novel recurrent amplified oncogenes in pediatric medulloblastoma
2007
-
Multiple recurrent genetic events converge on proper control of histone 3 lysine 9 methylation in pediatric medulloblastoma
2007
-
Stabilization for 9 months of rapidly progressive malignant glioma using bevacizumab, irinotecan, and temozolomide in a previously heavily treated 15-year-old female
2007
-
White matter integrity and core cognitive functions in children treated with cranial-spinal radiation: A diffusion tensor study
2007
-
Imaging findings related to adjuvant dendritic cell (DC) vaccination in patients with relapsed high-grade glioma
2006
-
Prodige: A phase 3 randomized placebo-controlled trial of thromboprophylaxis using dalteparin low-molecular-weight heparin (LMWH) in patients with newly diagnosed malignant glioma
2005
-
High-resolution longitudinal screening with magnetic resonance imaging in a murine brain cancer model
2004
-
Intensive therapy for childhood atypical teratoid rhabdold tumor of the central nervous system: A single institution's experience with four cases and a review of the literature
2004
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)